Insider · CIK 0001213308

THANGARAJ IMMANUEL

Reports to the SEC for 1 company · PALATINE, IL

sec.gov

Transactions

Companies

Filings

CIK

0001213308

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+50K sh	—	—	547,647
2026-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	0
2026-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)A Award	Director	AAward	−50K sh	—	—	50,000
2025-01-02	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+50K sh	—	—	497,647
2025-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	0
2025-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)A Award	Director	AAward	−50K sh	—	—	50,000
2024-01-02	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+50K sh	—	—	447,647
2024-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	0
2024-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)A Award	Director	AAward	−50K sh	—	—	50,000
2023-01-03	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+66.7K sh	—	—	397,647
2023-01-03	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)M Exercise/Conversion	Director	MExercise/Conversion	−66.7K sh	—	—	0
2023-01-03	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)A Award	Director	AAward	−50K sh	—	—	50,000
2022-01-03	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+66.7K sh	—	—	330,981
2022-01-03	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)M Exercise/Conversion	Director	MExercise/Conversion	−66.7K sh	—	—	0
2022-01-03	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)A Award	Director	AAward	−66.7K sh	—	—	66,666
2021-05-25	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2021 Plan)A Award	Director	AAward	+66.7K sh	—	—	66,666
2021-01-04	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+54.8K sh	—	—	264,315
2021-01-04	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2017 Plan)M Exercise/Conversion	Director	MExercise/Conversion	−54.8K sh	—	—	0
2020-01-02	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+83.3K sh	—	—	209,525
2020-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2017 Plan)M Exercise/Conversion	Director	MExercise/Conversion	−83.3K sh	—	—	0
2020-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2017 Plan)A Award	Director	AAward	+54.8K sh	—	—	54,790
2019-01-02	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+66.7K sh	—	—	126,192
2019-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2017 Plan)M Exercise/Conversion	Director	MExercise/Conversion	−66.7K sh	—	—	0
2019-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock Units (2017 Plan)A Award	Director	AAward	+83.3K sh	—	—	83,333
2018-01-02	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+35.7K sh	—	—	59,526
2018-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	+35.7K sh	—	—	23,809
2018-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−23.8K sh	$0.40	−$9,616.455	0
2018-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsA Award	Director	AAward	+66.7K sh	—	—	66,666
2017-01-03	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+13.2K sh	—	—	23,812
2017-01-03	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−8,810 sh	$0.77	−$6,752.865	13,216
2017-01-03	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−13.2K sh	—	—	0
2017-01-03	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsA Award	Director	AAward	+59.5K sh	—	—	59,523
2016-01-04	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+6,185 sh	—	—	10,596
2016-01-04	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,124 sh	$2.50	−$10.3K	6,185
2016-01-04	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,185 sh	—	—	0
2016-01-04	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsA Award	Director	AAward	+22K sh	—	—	22,026
2015-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−22.1K sh	—	—	14,705
2015-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−14.7K sh	—	—	0
2015-01-02	ACURA PHARMACEUTICALS, INCRestricted Stock UnitsA Award	Director	AAward	+51.5K sh	—	—	51,546
2014-01-02	ACURA PHARMACEUTICALS, INCM Exercise/Conversion	Director	MExercise/Conversion	+22.1K sh	—	—	22,059
2013-01-02	ACURA PHARMACEUTICALS, INCDirector Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000
2012-01-03	ACURA PHARMACEUTICALS, INCDirector Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000
2011-01-03	ACURA PHARMACEUTICALS, INCDirector Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000
2010-01-04	ACURA PHARMACEUTICALS, INCDirector Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000
2009-01-02	ACURA PHARMACEUTICALS, INCDirector Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000
2005-09-30	ACURA PHARMACEUTICALS, INCJ Other	Director	JOther	+79.2K sh	$0.61	+$48.3K	505,940
2005-06-30	ACURA PHARMACEUTICALS, INCJ Other	Director	JOther	+72.3K sh	$0.63	+$45.5K	426,745
2005-03-31	ACURA PHARMACEUTICALS, INCJ Other	Director	JOther	+70.5K sh	$0.61	+$43K	1,080,877
2004-12-31	ACURA PHARMACEUTICALS, INCJ Other	Director	JOther	+97.5K sh	$0.43	+$41.9K	303,620
2004-09-30	ACURA PHARMACEUTICALS, INCJ Other	Director	JOther	+91.7K sh	$0.43	+$39.4K	206,170

Recent filings

Accepted (ET)
Jan 154
THANGARAJ IMMANUEL0001104659-26-004053
SEC(opens sec.gov)
Feb 44
THANGARAJ IMMANUEL0001104659-25-008916
SEC(opens sec.gov)
Jan 24
THANGARAJ IMMANUEL0001104659-24-000284
SEC(opens sec.gov)
Jan 54
THANGARAJ IMMANUEL0001104659-23-001403
SEC(opens sec.gov)
Jan 124
THANGARAJ IMMANUEL0001104659-22-003594
SEC(opens sec.gov)
May 284
THANGARAJ IMMANUEL0001104659-21-074153
SEC(opens sec.gov)
Jan 124
THANGARAJ IMMANUEL0001104659-21-003437
SEC(opens sec.gov)
Jan 84
THANGARAJ IMMANUEL0001104659-20-002280
SEC(opens sec.gov)

Companies

ACURA PHARMACEUTICALS, INCDirector

Address

ACURA PHARMACEUTICALS INC 616 N. NORTH COURT, SUITE 120

PALATINE, IL, 60067